First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy

J Clin Oncol. 2006 Feb 1;24(4):e6-7. doi: 10.1200/JCO.2005.03.8083.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / metabolism
  • Adult
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Eosinophilia / complications*
  • Eosinophilia / metabolism
  • Humans
  • Imatinib Mesylate
  • Male
  • Mastocytosis, Systemic / diagnosis*
  • Mastocytosis, Systemic / metabolism
  • Monomeric GTP-Binding Proteins / analysis*
  • Piperazines / therapeutic use*
  • Polymorphism, Restriction Fragment Length
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-kit / genetics
  • Pyrimidines / therapeutic use*
  • Receptor, Platelet-Derived Growth Factor beta / analysis
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor beta
  • RRAGA protein, human
  • Monomeric GTP-Binding Proteins